NUMBZ 7-OH + MIT Chewable Tablets
The NUMBZ 7-OH + MIT 300mg 10pk 20ct is a wholesale master SKU of concentrated 7-hydroxymitragynine (7-OH) + mitragynine (MIT) extract chewable tablets, packaged for retail sale in smoke shops, specialty stores, and adult extract product categories. These tablets are formulated to deliver a total of 15 mg of active alkaloid blend (7-hydroxymitragynine + mitragynine) per tablet, presented in a 10-count retail pack format with 20 packs per master case—yielding 200 tablets total per case for structured inventory, shelving, and restock planning. Product labeling on each retail pack clearly identifies tablet strength (15 mg total alkaloids), count (10 tablets), and brand identity, supporting straightforward SKU recognition and merchandising across pegboards, counter racks, and display shelves within extract tablet offerings.
NUMBZ 7-OH + MIT 300mg
Key Benefits
• Wholesale Pack—20 packs of 10 tablets each (200 tablets total), supporting efficient restocking and assortment management.
• Dual-alkaloid blend—combines 7-hydroxymitragynine (7-OH) with mitragynine (MIT) in each tablet for standardized extract across packs.
• Portable chewable format—compact, ready-to-merchandise packs that fit counter racks, pegboards, or shelves without additional repackaging.
• Clear SKU labeling—strength, count, and brand details support rapid identification for retail sales and inventory control.
• Flavor versatility—available in multiple flavor variants (e.g., Kiwi Apple, Strawberry Dragonfruit) to diversify retail assortments.
Ingredients & Details
• Active Alkaloids: 7-hydroxymitragynine + mitragynine blend—15 mg total per tablet (combined).
• Inactive Ingredients: Natural binders & fillers such as microcrystalline cellulose, magnesium stearate, silica oxide, dicalcium phosphate, and food-grade colorants commonly found in chewable extract tablets.
NUMBZ 7-OH + MIT chewable tablets are available in various flavor options—including Kiwi Apple, Strawberry Dragonfruit, and Mint—and combine a dual-alkaloid profile where 7-hydroxymitragynine and mitragynine are blended into a moderate-strength chewable format, often positioned in extract categories where mid-range potency options are stocked alongside higher and lower strength variants. The packaging and master case structure help retailers maintain variety offerings and volume ordering workflows without frequent restocks.
Note: Products containing concentrated 7-hydroxymitragynine carry significant health risks and lack FDA approval; they may pose serious opioid-like effects and regulatory/legal status can vary by jurisdiction. Always follow applicable laws and health guidance.